Kurt Spiteri Cornish

Sheffield Teaching Hospitals NHS Trust, London, UK.

JOURNAL REVIEWED: Current Eye Research

Latest Contribution

Bromfenac versus betamethasone in diabetic macular oedema

31 October 2023 | | Retina / Uvea / Vitreous | Diabetic macular edema, betamethasone, bromfenac, central subfield thickness, intraocular pressure

This is a randomised, prospective, single-centre trial in patients diagnosed with diabetic macular oedema (DMO) with central subfield thickness (CST) of 250-500µm, who refused anti-VEGF treatment. Nineteen eyes of 19 patients were randomised to bromfenac (BF) or betamethasone (BM) drops,...

Brolucizumab in age-related macular degeneration, HAWK Study

3 October 2023 | | Retina / Uvea / Vitreous | Neovascular age-related macular degeneration, aflibercept, anti-vascular endothelial growth factor therapy, brolucizumab, commercial formulation

The aim of the study was to collect additional data on efficacy and safety of brolucizumab 6mg intended for commercialization in age-related macular degeneration (AMD) (with an increase in pH and decrease in polysorbate concentration). The HAWK Study was a...

Effect of heredity on risk of diabetic retinopathy

1 September 2023 | | Retina / Uvea / Vitreous | Diabetic macular edema, heredity, proliferative diabetic retinopathy, risk factors, survival analysis

This study used survival analysis on 2199 patients who had reached vision-threatening diabetic retinopathy to investigate the contribution of heredity to diabetes together with other known risk factors for the development of either proliferative diabetic retinopathy (PDR) or diabetic macular...